PTNT4.SA $6.54 3.481%
8208.HK $0.03 0%
2016.HK $2.92 -0.3413%
EPHE $26.40 -1.4558%
0293.HK $7.43 -1.328%
0918.HK $0.21 0%
BBDC $7.37 -0.0678%
1228.HK $1.60 6.6667%
ROU.BR $17.50 -1.6854%
EIS $54.20 -1.1091%
CPP.L $208.00 1.9608%
CIIG $8.75 0%
PSM $29.55 0%
ISUS.L $4 737.50 0.2009%
BLZE $4.27 0.9456%
0QLM.L $23.62 1.1476%
0665.HK $0.69 -1.4286%
HCICU $10.05 0%
0839.HK $7.15 -2.9851%
BHFAP $20.91 -0.1967%
RRR $45.51 1.1333%
GHM $11.67 -1.519%
BCDA $2.04 1.88%
GID.PA $0.80 0%
DWX $35.12 -0.791%
ICP.L $1 287.50 0.9408%
TWKS $7.63 -0.2614%
1771.HK $1.06 0%
VMO $9.43 -0.2033%
LYNX.CN $0.06 0%
NIQ $12.82 0.4191%
ESGE.PA $29.78 0.4655%
0274.HK $0.13 3.9062%
BSJR $21.59 -0.4156%
SZC $40.78 0%
CSAN3.SA $16.26 -0.7932%
IBN $22.89 -0.2832%
GSEU $33.90 -0.2651%
L100.L $1 267.30 0.2769%
HERO $20.13 -1.4197%
FISI $15.91 0.0314%
0JMU.L $26.20 0%
NCV $3.27 -1.2085%
OZON $11.60 0%
1933.HK $0.18 -2.139%
SWM $23.41 0%
BAC-PQ $18.14 -0.3006%
FUSE-UN $10.66 0%
SCHI $44.49 -0.4871%
ARGO-PA $21.99 0.0455%
SRTY $53.92 2.3344%
PRSRW $0.04 -39.5%
XCO2.L $15.17 -0.0659%
NEXTS.PA $105.00 0%
ICPT $15.82 1.2804%
MAG $11.66 1.3913%
UFS $55.49 0%
NBPU.L $19.50 -2.5%
SENS.L $0.35 0%
SQZ $0.62 3.3333%
TPBAU $11.32 0%
OWL $10.07 -1.5166%
0P3V.L $0.08 14.2857%
CBNK $15.71 0.5118%
JARA.L $91.20 -0.4367%
1940.HK $0.41 2.5%
SKL.L $20.00 -2.439%
3633.HK $6.10 0%
LSC.L $3 050.00 0%
MGAM $0.55 -3.1403%
TPOS.L $1 559.49 0.7745%
BBTP.L $75.42 -0.182%
XLRN $178.75 0%
8187.HK $0.20 -1.5152%
IMCB $58.69 -0.475%
CRG.IR $45.16 -0.243%
G500.L $5 228.85 0.4293%
MOM $21.54 0%
SMM $8.95 0%
QQQN $24.59 0.4433%
SAMA $10.34 0%
0171.HK $0.32 0%
DASA3.SA $11.01 -6.1381%
ARGUU $10.23 0%
FICV $10.30 -0.0485%
IDAT $21.21 0.2018%
CCS.L $7.50 -6.25%
PDD $63.11 -3.161%
EPS $43.43 -0.686%
LCAAU $10.41 0%
FOX.L $1.09 0%
ONEO $91.23 -0.3207%
AWAT.PA $25.29 0.4569%
2193.HK $0.31 -1.5873%
ET-PC $23.89 0.6179%
BAHI3.SA $9.77 0%
ONTXW $0.07 0%
3316.HK $23.10 -1.4925%
AMAT.L $114.95 0.393%
Eng
Логотип
Eng
Лого

uniQure N.V. 0EE0.L

$21.87

-$0.32 (-1.48%)
На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    8233718.00000000

  • week52high

    27.78

  • week52low

    13.28

  • Revenue

  • P/E TTM

    0

  • Beta

    1.16989600

  • EPS

    6.88700000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    07 мая 2023 г. в 04:58

Описание компании

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек